ORGANON SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Organon & Co. - OGN

1. Investors can file class action claims against OGN until July 22, 2025. 2. Lawsuit cites failure to disclose material information during specified period. 3. Dividend payout was reduced drastically, leading to significant share price drop. 4. OGN shares fell from $12.93 to $9.45 after the damaging announcement. 5. Lawsuit is filed in the U.S. District Court for New Jersey.

Legal

95

5m saved

Insight

Article

FAQ

Why Very Bearish?

The drastic cut in dividends combined with ongoing legal issues negatively impacts investor confidence, reminiscent of past securities violations affecting share prices significantly.

How important is it?

The class action lawsuit directly affects investor sentiment and financial stability for OGN.

Why Short Term?

Short-term volatility expected due to immediate legal proceedings and market reaction to dividend changes.

Related Companies

MCK MRK PFE

NEW ORLEANS, May 30, 2025 /PRNewswire/

ClaimsFiler, a FREE shareholder information service, reminds investors that they have until July 22, 2025 to file lead plaintiff applications in a securities class action lawsuit against Organon & Co. (NYSE: OGN), if they purchased the Company's securities between October 31, 2024 and April 30, 2025, inclusive (the "Class Period"). This action is pending in the United States District Court for the District of New Jersey.

Get Help

Organon investors should visit us at https://claimsfiler.com/cases/nyse-ogn/ or call toll-free (844) 367-9658. Lawyers at Kahn Swick & Foti, LLC are available to discuss your legal options.

About the Lawsuit

Organon and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.

On March 10, 2025, pre-market, the Company announced its financial results for the first quarter of 2025, disclosing, among other things, that management had reset the Company's dividend payout, from $0.28 to $0.02, contradicting its prior statements assuring investors that the regular quarterly dividend was a number one priority and that the Company was committed to its capital allocation strategy through the aforementioned dividend. On this news, the price of Organon's shares fell more than 27%, from a closing market price of $12.93 per share on April 30, 2025, to $9.45 per share on May 1, 2025.

The case is Hauser V. Organon & Co., et al., No. 25-cv-05322.

About ClaimsFiler

ClaimsFiler has a single mission: to serve as the information source to help retail investors recover their share of billions of dollars from securities class action settlements. At ClaimsFiler.com, investors can:

register for free to gain access to information and settlement websites for various securities class action cases so they can timely submit their own claims;
upload their portfolio transactional data to be notified about relevant securities cases in which they may have a financial interest;
submit inquiries to the Kahn Swick & Foti, LLC law firm for free case evaluations.

To learn more about ClaimsFiler, visit www.claimsfiler.com.

SOURCE ClaimsFiler